|
|
|
|
2010-1-13
Plant original: Pausinystalia Yohimbe
Specifications: 8~98% Yohimbine HCL by HPLC
Molecular...
yohimbine
|
2010-1-13
Plant original: Epimedium brevicornum, Epimedium sagittatum
Specifications: 10~98% Icariin by...
Epimedium, Icariin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009-10-28
Dasatinib (BMS-354825) is a novel, oral, potent, multi-targeted kinase inhibitor of Bcr-Abl and Src...
Dasatinib Monohydrate
|
2009-10-28
Lapatinib is a promising new breast cancer medication. It is an oral therapy targeting...
Lapatinib Dihydrate
|
2009-10-28
Use: Sorafenib is the first oral multi-kinase inhibitor that targets serine/ threonine and receptor...
Sorafenib tosylate
|
2009-10-28
CAS No.: [115909-22-3]
Molecular Weight: 784.755
Molecular Formula: C 36 H 48O19
Purity: >98%...
Angoroside C
|
2009-10-28
Sunitinib (marketed as Sutent, previously known as SU11248) is a small molecule receptor tyrosine...
Sunitinib malate
|
2009-10-28
Erlotinib is used to treat advanced non-small cell lung cancer (NSCLC), an aggressive type of lung...
Erlotinib HCL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|